Exact Mass: 291.2674

Exact Mass Matches: 291.2674

Found 67 metabolites which its exact mass value is equals to given mass value 291.2674, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Penbutolol

(2S)-1-(tert-butylamino)-3-(2-cyclopentylphenoxy)propan-2-ol

C18H29NO2 (291.2198)


Penbutolol is only found in individuals that have used or taken this drug. It is a medication in the class of beta blockers, used in the treatment of high blood pressure. [Wikipedia]Penbutolol competes with adrenergic neurotransmitters such as catecholamines for binding at beta(1)-adrenergic receptors in the heart and vascular smooth muscle and beta(2)-receptors in the bronchial and vascular smooth muscle. Beta(1)-receptor blockade results in a decrease in resting and exercise heart rate and cardiac output, a decrease in both systolic and diastolic blood pressure, and, possibly, a reduction in reflex orthostatic hypotension. C - Cardiovascular system > C07 - Beta blocking agents > C07A - Beta blocking agents > C07AA - Beta blocking agents, non-selective C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents

   

NCIOpen2_002822

17beta-Amino-5alpha-androstan-11beta-ol

C19H33NO (291.2562)


   

Exaprolol

1-(2-cyclohexylphenoxy)-3-[(propan-2-yl)amino]propan-2-ol

C18H29NO2 (291.2198)


C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists

   

Ketocaine

1-(2-(2-(Bis(1-methylethyl)amino)ethoxy)phenyl)-1-butanone

C18H29NO2 (291.2198)


C78272 - Agent Affecting Nervous System > C245 - Anesthetic Agent

   

Acetyldihydrolycopodine

Acetyldihydrolycopodine

C18H29NO2 (291.2198)


   

Lanyuamide II

Lanyuamide II

C18H29NO2 (291.2198)


   

(2E,4E,8Z,11Z)-2-hydroxy-N-isobutyl-2,4,8,11-tetradecatetraenamide|(2E,4E,8Z,11Z)-N-(2-hydroxy-2-methylpropyl)-2,4,8,11-tetradecatetraenamide|bungeanool|N-(2-methyl-2-hydroxypropyl)tetradeca-(2E,4E,8Z,11Z)-tetraeneamide

(2E,4E,8Z,11Z)-2-hydroxy-N-isobutyl-2,4,8,11-tetradecatetraenamide|(2E,4E,8Z,11Z)-N-(2-hydroxy-2-methylpropyl)-2,4,8,11-tetradecatetraenamide|bungeanool|N-(2-methyl-2-hydroxypropyl)tetradeca-(2E,4E,8Z,11Z)-tetraeneamide

C18H29NO2 (291.2198)


   

DTXSID90788961

DTXSID90788961

C19H33NO (291.2562)


   

(2E,4E,8Z,11Z)-2-Hydroxy-N-isobutyl-2,4,8,11-tetradecatetraenamide

(2E,4E,8Z,11Z)-2-Hydroxy-N-isobutyl-2,4,8,11-tetradecatetraenamide

C18H29NO2 (291.2198)


   

5-Hydroxy-2-methyl-6-(11-oxododecyl)-pyridine|5-hydroxy-2-methyl-6-(11-oxododecyl)pyridine

5-Hydroxy-2-methyl-6-(11-oxododecyl)-pyridine|5-hydroxy-2-methyl-6-(11-oxododecyl)pyridine

C18H29NO2 (291.2198)


   
   
   

(2E,4E,8Z,10E)-12-hydroxy-N-(2-methylpropyl)tetradeca-2,4,8,10-tetraenamide|Lanyuamide VI

(2E,4E,8Z,10E)-12-hydroxy-N-(2-methylpropyl)tetradeca-2,4,8,10-tetraenamide|Lanyuamide VI

C18H29NO2 (291.2198)


   

291A Octahydrohistrionicotoxin

291A Octahydrohistrionicotoxin

C19H33NO (291.2562)


   

7-multijuguinone

7-multijuguinone

C18H29NO2 (291.2198)


   

Mycalazal 14

Mycalazal 14

C19H33NO (291.2562)


   

(+/-)-3,4-dihydro-5-methyl-4-n-pentadec-(7Z)-enyl-2H-pyrrole

(+/-)-3,4-dihydro-5-methyl-4-n-pentadec-(7Z)-enyl-2H-pyrrole

C20H37N (291.2926)


   

(2E,4E,8Z)-12-keto-N-isobutyl-2,4,8-tetradecatrienamide|Lanyuamide II

(2E,4E,8Z)-12-keto-N-isobutyl-2,4,8-tetradecatrienamide|Lanyuamide II

C18H29NO2 (291.2198)


   

Penbutolol

Penbutolol

C18H29NO2 (291.2198)


C - Cardiovascular system > C07 - Beta blocking agents > C07A - Beta blocking agents > C07AA - Beta blocking agents, non-selective C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents

   

(2R,6R,7S,8S)-7-(but-3-en-1-yl)-2-(pent-4-en-1-yl)-1-azaspiro[5.5]undecan-8-ol

(2R,6R,7S,8S)-7-(but-3-en-1-yl)-2-(pent-4-en-1-yl)-1-azaspiro[5.5]undecan-8-ol

C19H33NO (291.2562)


   

(8S,Z)-6-((R,E)-2,5-dimethyloct-4-en-1-ylidene)-8-methyloctahydroindolizin-8-ol

(8S,Z)-6-((R,E)-2,5-dimethyloct-4-en-1-ylidene)-8-methyloctahydroindolizin-8-ol

C19H33NO (291.2562)


   

(7R,E)-4,7-dimethyl-8-((8R,Z)-8-methylhexahydroindolizin-6(5H)-ylidene)oct-4-en-3-ol

(7R,E)-4,7-dimethyl-8-((8R,Z)-8-methylhexahydroindolizin-6(5H)-ylidene)oct-4-en-3-ol

C19H33NO (291.2562)


   

Isobungeanool

2-hydroxy-N-(isobutyl)-tetradeca-2E,4E,8Z,11E-tetraenamide

C18H29NO2 (291.2198)


   

Bungeanool

2-hydroxy-N-(isobutyl)-tetradeca-2E,4E,8Z,11Z-tetraenamide

C18H29NO2 (291.2198)


   
   

2,4,6-Tri-tert-butylnitrobenzene

2,4,6-Tri-tert-butylnitrobenzene

C18H29NO2 (291.2198)


   

3,3-(Dodecylimino)dipropanenitrile

3,3-(Dodecylimino)dipropanenitrile

C18H33N3 (291.2674)


   

N,N,N-Trimethyl-1-tetradecanaminium chloride

N,N,N-Trimethyl-1-tetradecanaminium chloride

C17H38ClN (291.2693)


   

N-[2-[2-(2-aminoethylamino)ethylamino]ethyl]ethane-1,2-diamine,2-methyloxirane,oxirane

N-[2-[2-(2-aminoethylamino)ethylamino]ethyl]ethane-1,2-diamine,2-methyloxirane,oxirane

C13H33N5O2 (291.2634)


   

Dodecanamide,N-(4-hydroxyphenyl)-

Dodecanamide,N-(4-hydroxyphenyl)-

C18H29NO2 (291.2198)


   

3-(2,4-DI-T-PENTYLPHENOXY)PROPYLAMINE

3-(2,4-DI-T-PENTYLPHENOXY)PROPYLAMINE

C19H33NO (291.2562)


   

Testosterone-d3

Testosterone-d3

C19H25D3O2 (291.2278)


   

1-(4-tert-butylphenyl)-3-[3-(propan-2-ylamino)propyl]urea

1-(4-tert-butylphenyl)-3-[3-(propan-2-ylamino)propyl]urea

C17H29N3O (291.2311)


   

4-methoxy-2,2,6,6-tetramethyl-1-(1-phenylethoxy)piperidine

4-methoxy-2,2,6,6-tetramethyl-1-(1-phenylethoxy)piperidine

C18H29NO2 (291.2198)


   

(+)-Penbutolol

(+)-Penbutolol

C18H29NO2 (291.2198)


(+)-Penbutolol is a β-adrenoceptor antagonist, with an IC50 of 0.74 μM[1]. (+)-Penbutolol is an optical isomer of l-penbutolol with Na+ channel-blocking action[2].

   

17-Amino-5alpha-androstan-11-ol

17-Amino-5alpha-androstan-11-ol

C19H33NO (291.2562)


   
   

(4Z,7Z,10Z,13Z)-N-(2-hydroxyethyl)hexadeca-4,7,10,13-tetraenamide

(4Z,7Z,10Z,13Z)-N-(2-hydroxyethyl)hexadeca-4,7,10,13-tetraenamide

C18H29NO2 (291.2198)


   

17beta-Amino-5alpha-androstan-11beta-ol

17beta-Amino-5alpha-androstan-11beta-ol

C19H33NO (291.2562)


   

(2e,4e)-n-(2-hydroxy-2-methylpropyl)tetradeca-2,4,8,11-tetraenimidic acid

(2e,4e)-n-(2-hydroxy-2-methylpropyl)tetradeca-2,4,8,11-tetraenimidic acid

C18H29NO2 (291.2198)


   

(2e,4e,8e,11e)-n-(2-hydroxy-2-methylpropyl)tetradeca-2,4,8,11-tetraenimidic acid

(2e,4e,8e,11e)-n-(2-hydroxy-2-methylpropyl)tetradeca-2,4,8,11-tetraenimidic acid

C18H29NO2 (291.2198)


   

12-hydroxy-n-(2-methylpropyl)tetradeca-2,4,8,10-tetraenimidic acid

12-hydroxy-n-(2-methylpropyl)tetradeca-2,4,8,10-tetraenimidic acid

C18H29NO2 (291.2198)


   

(2e,4 e,8z,11e)-2'-hydroxy-n-isobutyl-2,4,8,11-tetradecatetraenamide

NA

C18H29NO2 (291.2198)


{"Ingredient_id": "HBIN005558","Ingredient_name": "(2e,4 e,8z,11e)-2'-hydroxy-n-isobutyl-2,4,8,11-tetradecatetraenamide","Alias": "NA","Ingredient_formula": "C18H29NO2","Ingredient_Smile": "CCC=CCC=CCCC=CC=CC(=O)NCC(C)(C)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "10235","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

   

(2e,4 e,8z,11z)-2'-hydroxy-n-isobutyl-2,4,8,11-tetradecatetraenamide

NA

C18H29NO2 (291.2198)


{"Ingredient_id": "HBIN005559","Ingredient_name": "(2e,4 e,8z,11z)-2'-hydroxy-n-isobutyl-2,4,8,11-tetradecatetraenamide","Alias": "NA","Ingredient_formula": "C18H29NO2","Ingredient_Smile": "CCC=CCC=CCCC=CC=CC(=O)NCC(C)(C)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "10236","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

   

5-hydroxy-2-methyl-6-(11'-oxododecyl)-pyridine

NA

C18H29NO2 (291.2198)


{"Ingredient_id": "HBIN011591","Ingredient_name": "5-hydroxy-2-methyl-6-(11'-oxododecyl)-pyridine","Alias": "NA","Ingredient_formula": "C18H29NO2","Ingredient_Smile": "CC1=NC(=C(C=C1)O)CCCCCCCCCCC(=O)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "10509","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

   

12-(3-hydroxy-6-methylpyridin-2-yl)dodecan-2-one

12-(3-hydroxy-6-methylpyridin-2-yl)dodecan-2-one

C18H29NO2 (291.2198)


   

7-(but-3-en-1-yl)-2-(pent-4-en-1-yl)-1-azaspiro[5.5]undecan-8-ol

7-(but-3-en-1-yl)-2-(pent-4-en-1-yl)-1-azaspiro[5.5]undecan-8-ol

C19H33NO (291.2562)


   

(2e,4e,11e)-n-(2-hydroxy-2-methylpropyl)tetradeca-2,4,8,11-tetraenimidic acid

(2e,4e,11e)-n-(2-hydroxy-2-methylpropyl)tetradeca-2,4,8,11-tetraenimidic acid

C18H29NO2 (291.2198)


   

mycalenitrile-15

mycalenitrile-15

C19H33NO (291.2562)


   

(2e,4e)-1-(piperidin-1-yl)tetradeca-2,4-dien-1-one

(2e,4e)-1-(piperidin-1-yl)tetradeca-2,4-dien-1-one

C19H33NO (291.2562)


   

n-(2-methylpropyl)-12-oxotetradeca-2,4,8-trienimidic acid

n-(2-methylpropyl)-12-oxotetradeca-2,4,8-trienimidic acid

C18H29NO2 (291.2198)


   

(8r)-7-(but-3-en-1-yl)-2-(pent-4-en-1-yl)-1-azaspiro[5.5]undecan-8-ol

(8r)-7-(but-3-en-1-yl)-2-(pent-4-en-1-yl)-1-azaspiro[5.5]undecan-8-ol

C19H33NO (291.2562)


   

(2e,4e,8z,10e,12r)-12-hydroxy-n-(2-methylpropyl)tetradeca-2,4,8,10-tetraenimidic acid

(2e,4e,8z,10e,12r)-12-hydroxy-n-(2-methylpropyl)tetradeca-2,4,8,10-tetraenimidic acid

C18H29NO2 (291.2198)


   

2-methyl-3-(pentadec-7-en-1-yl)-4,5-dihydro-3h-pyrrole

2-methyl-3-(pentadec-7-en-1-yl)-4,5-dihydro-3h-pyrrole

C20H37N (291.2926)


   

(3s)-2-methyl-3-[(7z)-pentadec-7-en-1-yl]-4,5-dihydro-3h-pyrrole

(3s)-2-methyl-3-[(7z)-pentadec-7-en-1-yl]-4,5-dihydro-3h-pyrrole

C20H37N (291.2926)


   

(2e,4e,8z,11e)-n-(2-hydroxy-2-methylpropyl)tetradeca-2,4,8,11-tetraenimidic acid

(2e,4e,8z,11e)-n-(2-hydroxy-2-methylpropyl)tetradeca-2,4,8,11-tetraenimidic acid

C18H29NO2 (291.2198)


   

(2s)-1-[(2s,6r)-6-[(2s)-2-hydroxy-2-phenylethyl]-1-methylpiperidin-2-yl]butan-2-ol

(2s)-1-[(2s,6r)-6-[(2s)-2-hydroxy-2-phenylethyl]-1-methylpiperidin-2-yl]butan-2-ol

C18H29NO2 (291.2198)


   

n-(2-hydroxy-2-methylpropyl)tetradeca-2,4,8,11-tetraenimidic acid

n-(2-hydroxy-2-methylpropyl)tetradeca-2,4,8,11-tetraenimidic acid

C18H29NO2 (291.2198)


   

(2e,4e)-n-(2-methylpropyl)-12-oxotetradeca-2,4,8-trienimidic acid

(2e,4e)-n-(2-methylpropyl)-12-oxotetradeca-2,4,8-trienimidic acid

C18H29NO2 (291.2198)


   

(2e,4e,8z)-n-(2-methylpropyl)-12-oxotetradeca-2,4,8-trienimidic acid

(2e,4e,8z)-n-(2-methylpropyl)-12-oxotetradeca-2,4,8-trienimidic acid

C18H29NO2 (291.2198)


   

1-[6-(2-hydroxy-2-phenylethyl)-1-methylpiperidin-2-yl]butan-2-ol

1-[6-(2-hydroxy-2-phenylethyl)-1-methylpiperidin-2-yl]butan-2-ol

C18H29NO2 (291.2198)


   

(1r,2r,10s,11r,13s,15r)-15-methyl-6-azatetracyclo[8.6.0.0¹,⁶.0²,¹³]hexadecan-11-yl acetate

(1r,2r,10s,11r,13s,15r)-15-methyl-6-azatetracyclo[8.6.0.0¹,⁶.0²,¹³]hexadecan-11-yl acetate

C18H29NO2 (291.2198)


   

15-methyl-6-azatetracyclo[8.6.0.0¹,⁶.0²,¹³]hexadecan-11-yl acetate

15-methyl-6-azatetracyclo[8.6.0.0¹,⁶.0²,¹³]hexadecan-11-yl acetate

C18H29NO2 (291.2198)


   

(2e,4e,8z)-n-[(2s)-butan-2-yl]-12-oxotetradeca-2,4,8-trienimidic acid

(2e,4e,8z)-n-[(2s)-butan-2-yl]-12-oxotetradeca-2,4,8-trienimidic acid

C18H29NO2 (291.2198)


   

(2e,4e,8z,11z)-n-(2-hydroxy-2-methylpropyl)tetradeca-2,4,8,11-tetraenimidic acid

(2e,4e,8z,11z)-n-(2-hydroxy-2-methylpropyl)tetradeca-2,4,8,11-tetraenimidic acid

C18H29NO2 (291.2198)


   

(2e,4e,8z,10e)-12-hydroxy-n-(2-methylpropyl)tetradeca-2,4,8,10-tetraenimidic acid

(2e,4e,8z,10e)-12-hydroxy-n-(2-methylpropyl)tetradeca-2,4,8,10-tetraenimidic acid

C18H29NO2 (291.2198)


   

(2e,4e,8z,10e)-7-hydroxy-n-(2-methylpropyl)tetradeca-2,4,8,10-tetraenimidic acid

(2e,4e,8z,10e)-7-hydroxy-n-(2-methylpropyl)tetradeca-2,4,8,10-tetraenimidic acid

C18H29NO2 (291.2198)